Johnson & Johnson revenue 2005-2023

In 2023, Johnson & Johnson's generated approximately 95 billion U.S. dollars in sales. This statistic shows the global total sales of Johnson & Johnson from 2005 to 2023. Johnson & Johnson is a multinational company, specialized in pharmaceuticals, medical devices, and consumer goods. The company is headquartered in New Brunswick, New Jersey.

Johnson & Johnson’s global position

Johnson & Johnson has been ranked among the top pharmaceutical companies globally in recent years and in multiple categories. As of 2023, it was ranked second among the leading pharmaceutical companies worldwide in terms of total revenue generated. Furthermore, Johnson and Johnson was also the third leading pharmaceutical company globally by prescription sales revenue in 2022, as well as being the second ranked company worldwide in terms of its research and development spending.

Johnson & Johnson’s research and development

As of 2022, Johnson and Johnson was also one of the big pharmaceutical companies with the highest R&D intensity. Johnson and Johnson’s research and development expenditure has been steadily and gradually increasing in the past five years. In 2023, the company spent over 15 billion U.S. dollars on research and development, accounting for nearly 18 percent of total sales revenue that year.